bovin
respiratori
diseas
brd
major
caus
increas
morbid
mortal
young
calv
brd
caus
substanti
econom
loss
cattl
industri
also
seen
anim
welfar
issu
sever
studi
demonstr
neg
econom
impact
increas
mortal
treatment
cost
reduc
growth
caus
brd
moreov
high
morbid
rate
lead
increas
use
antibiot
commonli
associ
emerg
antimicrobi
resist
togeth
veal
calf
oper
unit
europ
calf
rear
oper
finland
consum
reason
high
level
antibiot
recent
studi
publish
netherland
show
antimicrobi
consumpt
rate
veal
calf
farm
sever
time
higher
compar
pig
broiler
farm
public
concern
anim
welfar
emerg
antibiot
resist
put
pressur
industri
find
new
prevent
method
improv
anim
health
thu
reduc
use
antibiot
beef
product
chain
brd
multifactori
origin
caus
sever
differ
pathogen
either
alon
combin
earlier
studi
shown
brd
incid
highli
depend
environment
individu
farm
specif
factor
respiratori
syncyti
viru
corona
viru
parainfluenza
type
viru
pasteurella
multocida
histophilu
somni
mannheimia
haemolytica
ureaplasma
diversum
common
respiratori
pathogen
around
world
also
frequent
found
pathogen
cattl
respiratori
sampl
finland
mycoplasma
bovi
first
isol
finnish
cattl
respiratori
sampl
current
finland
free
infecti
bovin
rhinotrach
bovin
viral
diarrhea
beef
product
finland
mainli
base
rear
bull
calv
born
dairi
farm
separ
finish
farm
special
beef
product
bull
calv
commonli
either
pure
dairi
breed
dairybeef
cross
transport
separ
rear
unit
day
age
unlik
veal
calf
product
central
europ
north
america
calv
finland
slaughter
age
month
approxim
two
third
dairi
bull
calv
first
transport
special
calf
rear
unit
rear
month
transport
special
finish
farm
remain
calv
either
transport
finish
farm
directli
wean
integr
beef
product
farm
special
rear
unwean
calv
slaughter
age
prophylact
use
antibiot
rare
finland
unlik
mani
countri
vaccin
brd
commonli
use
finland
grow
size
calf
rear
unit
rise
incid
brd
forc
us
introduc
new
prevent
method
vaccin
calv
frequent
common
respiratori
pathogen
futur
could
one
part
solut
sinc
morbid
mortal
rate
usual
highest
first
week
arriv
calf
rear
unit
matern
antibodi
known
inhibitori
effect
parenter
administ
vaccin
develop
effect
vaccin
program
young
calv
problemat
block
effect
increas
interest
introduc
intranas
administr
vaccin
hill
other
show
day
old
holstein
calv
capabl
develop
mucos
immun
respons
intranas
vaccin
even
matern
antibodi
present
studi
intranas
vaccin
also
shown
promis
result
young
calv
day
old
vaccin
common
respiratori
pathogen
short
durat
immun
one
dose
intranas
vaccin
may
set
requir
subsequ
booster
vaccin
even
though
intranas
vaccin
reduc
incid
brd
studi
patholog
chang
lung
reduc
calv
transport
rear
unit
numer
farm
would
achiev
start
vaccin
calv
time
arriv
rear
unit
even
though
best
vaccin
effect
would
requir
vaccin
alreadi
transport
despit
increas
interest
intranas
vaccin
clinic
trial
avail
prove
efficaci
field
condit
primari
object
random
field
trial
evalu
effect
singl
dose
commerci
intranas
vaccin
treatment
incid
brd
daili
gain
calf
mortal
one
commerci
calf
rear
unit
upon
arriv
n
vaccin
calv
n
unvaccin
calv
assess
brd
tabl
serum
immunoglobulin
g
igg
concentr
time
arriv
refer
valu
mgml
n
vaccin
calv
n
control
calv
n
calv
overal
n
calv
serum
amyloid
saa
valu
higher
refer
valu
saa
refer
valu
exceed
n
n
vaccin
unvaccin
calv
respect
differ
measur
variabl
statist
signific
vaccin
unvaccin
calv
studi
period
calv
receiv
least
one
cours
antibiot
specif
calv
receiv
one
calv
receiv
two
calv
receiv
three
antibiot
cours
three
calv
antibiot
administ
three
time
diagnosi
total
antibiot
cours
target
brd
interdigit
phlegmon
unknown
fever
infect
umbil
inflamm
ear
inflamm
arthriti
two
type
antibiot
use
studi
period
parenter
oxytetracyclin
use
cours
parenter
benzylpenicillin
nonsteroid
antiinflammatori
drug
ad
everi
antimicrobi
cours
averag
time
first
medic
day
longer
vaccin
calv
compar
unvaccin
calv
tabl
differ
time
first
medic
statist
signific
group
weight
vaccin
calv
significantli
differ
unvaccin
calv
measur
wean
p
tabl
regress
model
vaccin
significantli
associ
daili
gain
wean
coef
p
femal
sex
calf
coef
p
older
age
arriv
unit
coef
p
posit
diagnosi
brd
first
clinic
examin
coef
p
associ
better
growth
milkfeed
period
independ
factor
model
breed
serum
saa
concentr
total
six
calv
exclud
model
one
due
miss
weight
data
five
due
untim
death
milkfeed
period
averag
daili
gain
calv
arriv
unit
end
studi
period
present
tabl
complet
studi
period
vaccin
calv
gain
averag
gday
unvaccin
calv
first
final
model
interact
vaccin
age
time
arriv
detect
fig
thereaft
two
differ
mix
regress
model
gener
one
calv
younger
day
n
anoth
calv
day
older
n
time
arriv
unit
vaccin
calv
significantli
better
growth
compar
unvaccin
control
calv
coef
p
model
calv
day
older
time
arriv
independ
factor
model
posit
associ
growth
weight
calf
arriv
coef
p
beef
breed
coef
p
femal
sex
coef
p
neg
affect
growth
model
calv
younger
day
time
arriv
vaccin
signific
effect
growth
coef
p
factor
posit
affect
growth
younger
calv
higher
weight
calf
time
arriv
unit
coef
p
total
calv
exclud
model
due
untim
death
studi
period
vaccin
calv
lower
odd
ratio
brd
diagnosi
second
clinic
examin
compar
unvaccin
calv
p
brd
diagnos
vaccin
unvaccin
calv
variabl
logist
regress
model
age
arriv
unit
p
brd
diagnosi
p
clinic
score
p
first
clinic
examin
none
variabl
statist
signific
effect
depend
variabl
total
five
calv
exclud
model
due
untim
death
milkfeed
period
total
calv
treat
brd
unvaccin
vaccin
calv
treat
two
time
unvaccin
vaccin
treat
three
time
unvaccin
vaccin
brd
studi
period
vaccin
calv
treat
brd
least
studi
period
unvaccin
calv
total
howev
differ
vaccin
unvaccin
calv
statist
signific
p
accord
mix
regress
model
test
probabl
calf
treat
brd
least
studi
period
factor
preserv
model
serum
igg
saa
level
arriv
unit
p
p
calf
weight
arriv
unit
p
brd
diagnosi
p
clinic
condit
arriv
unit
p
none
factor
statist
signific
effect
chanc
treat
brd
studi
calv
n
includ
model
mortal
studi
period
six
vaccin
six
unvaccin
calv
die
studi
period
three
whole
calv
two
lungheart
packag
sent
necropsi
determin
caus
death
pneumonia
determin
caus
death
two
control
calv
polyarticular
arthriti
combin
omphal
caus
death
one
vaccin
calf
unidentifi
gastrointestin
diseas
caus
death
one
control
calf
caus
death
could
determin
one
necropsi
calf
remain
seven
dead
calv
necropsi
mean
time
spent
unit
untim
death
day
sd
rang
differ
mortal
vaccin
unvaccin
calv
statist
signific
logist
mix
regress
model
p
one
factor
preserv
model
number
antimicrobi
treatment
addit
confound
factor
sex
breed
higher
number
antimicrobi
treatment
rear
period
significantli
increas
odd
calf
would
die
studi
period
p
studi
calv
n
includ
model
studi
brd
morbid
averag
daili
gain
mortal
calv
vaccin
intranas
brd
vaccin
rispov
rs
intranas
zoeti
compar
unvaccin
calv
one
commerci
calf
rear
unit
finland
vaccin
combin
older
arriv
age
day
older
result
significantli
greater
daili
gain
averag
g
compar
unvaccin
calv
differ
record
calv
arriv
younger
day
studi
vaccin
calv
vaccin
one
three
day
arriv
find
suggest
younger
calv
capabl
respond
vaccin
effect
older
calv
studi
need
determin
result
younger
calv
immatur
immun
system
inhibitori
effect
matern
antibodi
vaccin
also
show
trend
toward
increas
daili
gain
milkfeed
period
independ
age
time
arriv
addit
vaccin
lower
odd
ratio
brd
diagnosi
second
clinic
examin
efficaci
intranas
vaccin
demonstr
mani
experiment
challeng
studi
clinic
field
trial
avail
ollivett
other
conduct
field
trial
three
dairi
herd
intranas
vaccin
young
calv
bovin
rhinotrach
viru
respiratori
syncyti
viru
current
studi
conduct
calf
rear
unit
differ
challeng
studi
sever
way
studi
matern
antibodi
level
calf
serum
display
variat
time
vaccin
calv
natur
expos
wide
rang
pathogen
knew
earlier
studi
report
bovin
respiratori
syncyti
viru
viru
rather
common
pathogen
finnish
cattl
thu
quit
confid
pathogen
would
present
larg
rear
unit
use
studi
studi
efficaci
vaccin
field
condit
probabl
also
led
brd
case
caus
pathogen
includ
vaccin
outcom
examin
studi
daili
gain
wean
daili
gain
complet
studi
period
brd
diagnosi
second
clinic
examin
time
wean
number
antimicrobi
treatment
brd
mortal
studi
period
manufactur
recommend
vaccin
calv
alreadi
ten
day
period
stress
high
infect
risk
regroup
transport
order
achiev
optim
result
practic
difficult
implement
calv
often
multipl
origin
dairi
farmer
rare
motiv
vaccin
calv
shortli
leav
farm
feasibl
practic
could
vaccin
calv
time
arriv
calf
rear
unit
immedi
studi
awar
may
lead
decreas
efficaci
calv
might
get
infect
alreadi
vaccin
immun
success
develop
accord
knowledg
publish
efficaci
studi
similar
intranas
vaccin
protocol
prevent
brd
commerci
calf
rear
unit
nevertheless
practic
commonli
use
european
countri
studi
farm
personnel
use
differ
overal
boot
compart
first
ten
day
follow
vaccin
avoid
contamin
unvaccin
calv
potenti
nasal
shed
vaccin
calv
accord
vaccin
manufactur
data
shed
brsv
v
possibl
day
vaccin
respect
studi
report
even
longer
shed
time
accord
risk
spread
vaccin
virus
vaccin
calv
unvaccin
calv
via
contamin
overal
boot
possibl
even
ten
day
post
vaccin
author
awar
risk
consid
minim
brd
diagnosi
first
clinic
examin
associ
increas
growth
milkfeed
period
posit
associ
hard
explain
calf
transport
system
finland
base
rule
healthi
anim
accept
transport
decis
made
dairi
farmer
educ
driver
still
subject
decis
mild
sign
diseas
easili
miss
calf
otherwis
appar
healthi
bigger
calv
higher
growth
potenti
probabl
like
transport
despit
sick
wherea
small
older
lower
growth
potenti
calv
might
readili
exclud
might
lead
situat
slightli
ill
calv
high
growth
potenti
overrepres
studi
popul
time
arriv
brd
diagnosi
base
score
system
use
love
colleagu
differ
use
stethoscop
auscult
rather
visual
inspect
evalu
respiratori
sound
done
origin
score
system
assess
abnorm
respir
base
audio
sound
rather
visual
cue
might
led
find
higher
score
compar
origin
score
system
also
use
clinic
score
describ
overal
health
calf
time
clinic
examin
specif
calcul
sum
find
clinic
examin
knowledg
method
base
score
system
nevertheless
consid
use
account
diseas
condit
respiratori
diseas
assess
health
calv
vaccin
factor
significantli
decreas
risk
brd
diagnosi
second
clinic
examin
use
ultrasonographi
accur
detect
lung
lesion
would
given
inform
actual
statu
lung
recent
clinic
trial
intranas
vaccin
lower
odd
lung
consolid
compar
unvaccin
calv
even
though
overal
treatment
brd
reduc
similar
effect
might
explain
number
treatment
brd
reduc
current
studi
even
though
diagnos
brd
case
second
clinic
examin
reduc
thompson
other
show
associ
lung
lesion
decreas
daili
gain
slaughter
feedlot
cattl
studi
also
demonstr
exist
subclin
brd
show
lung
lesion
present
anim
never
treat
brd
could
also
explain
enhanc
daili
gain
vaccin
calv
studi
even
though
treatment
brd
reduc
studi
need
prove
theori
trend
toward
high
serum
igg
time
arriv
reduc
probabl
calf
treat
brd
similar
associ
low
serum
igg
level
higher
morbid
also
present
previou
studi
best
knowledg
studi
refer
valu
serum
igg
level
calv
week
old
two
day
old
calv
mgml
commonli
use
minimum
level
success
passiv
transfer
earlier
studi
shown
amount
igg
serum
decreas
slowli
birth
halflif
day
current
studi
calv
low
serum
igg
mgml
arriv
mean
age
day
treat
least
brd
compar
calv
high
serum
igg
mgml
arriv
mean
age
day
support
earlier
find
demonstr
success
passiv
transfer
matern
antibodi
import
health
calf
arriv
calv
serum
saa
higher
refer
valu
mgml
suggest
colleagu
calv
higher
serum
saa
concentr
gain
weight
slower
calv
lower
concentr
also
report
earlier
studi
elev
concentr
serum
saa
may
normal
calv
younger
two
week
old
may
reflect
exist
inflamm
alreadi
present
time
arriv
accord
clinic
examin
data
arriv
calv
suffer
either
heal
acut
inflamm
umbilicu
result
studi
promis
even
adapt
directli
calf
rear
unit
due
differ
pathogen
profil
larg
number
differ
origin
farm
may
even
caus
pathogen
profil
variat
consecut
batch
arriv
calv
accord
result
studi
would
worth
consid
transport
slightli
older
calv
calf
rear
unit
intranas
vaccin
use
administr
singl
intranas
dose
commerci
avail
vaccin
significantli
increas
daili
gain
calv
arriv
calf
rear
unit
age
day
older
vaccin
reduc
number
calv
medic
brd
lower
incid
diagnos
brd
time
wean
higher
number
antimicrobi
treatment
rear
period
significantli
increas
odd
prematur
death
random
field
trial
design
test
efficaci
singl
dose
commerci
intranas
vaccin
one
calf
rear
unit
studi
calv
vaccin
time
arriv
calv
serv
neg
control
unvaccin
clinic
examin
sampl
collect
carri
calv
two
time
arriv
wean
studi
calv
vaccin
first
clinic
examin
studi
period
start
day
first
clinic
examin
last
day
calv
transport
finish
unit
averag
day
sd
daili
gain
calcul
period
arriv
wean
milkfeed
period
arriv
transport
finish
unit
complet
studi
period
medic
record
whole
studi
period
blood
sampl
analyz
detect
possibl
low
serum
igg
level
high
saa
level
time
enrol
normal
oper
cycl
calf
rear
unit
remain
throughout
studi
period
studi
calv
transport
feedlot
finish
cattl
usual
none
calv
euthan
studi
studi
design
approv
advanc
anim
experiment
board
region
state
administr
agenc
finland
ref
number
studi
carri
four
similar
milkfeed
compart
one
privat
own
calf
rear
unit
locat
southwestern
finland
januari
januari
entir
unit
compris
six
separ
milkfeed
compart
two
larger
separ
uninsul
compart
older
calv
unit
oper
allin
allout
system
six
milkfeed
compart
empti
wash
disinfect
prior
everi
arriv
new
calv
unit
confirm
free
mycoplasma
bovi
milk
replac
primo
powermix
suomen
rehu
oy
finland
dispens
automat
milkfeed
system
total
kgcalf
milkfeed
period
calv
free
entri
silag
concentr
primo
kasvatu
suomen
rehu
oy
finland
compart
contain
one
larg
pen
solid
floor
feed
area
peatstraw
bed
rest
area
compart
insul
separ
ventil
system
base
automat
exhaust
fan
day
milkfeed
calv
gradual
wean
merg
calv
compart
one
larger
uninsul
compart
unlimit
mix
feed
supplement
kg
grate
barleyrapese
mixtur
offer
calv
daili
three
week
wean
end
studi
period
total
concentr
percent
around
calv
use
studi
n
transport
unit
seven
batch
averag
calv
per
batch
rang
four
similar
milkfeed
compart
averag
calv
refil
everi
two
month
twoweek
time
period
cycl
repeat
four
time
except
last
cycl
seventh
batch
two
compart
includ
studi
upon
arriv
transport
calv
randomli
alloc
two
differ
compart
fill
simultan
calv
one
two
compart
randomli
select
serv
neg
control
wherea
calv
compart
vaccin
commerci
intranas
vaccin
rispov
rs
intranas
zoeti
consist
modifi
live
bovin
respiratori
syncyti
viru
brsv
parainfluenza
type
viru
v
vaccin
perform
accord
manufactur
guidelin
total
seven
compart
vaccin
calv
seven
compart
unvaccin
calv
includ
studi
first
clinic
examin
sampl
collect
possibl
vaccin
perform
calf
veterinarian
one
three
day
arriv
unit
studi
farmer
remain
blind
regard
vaccin
statu
group
first
ten
day
follow
vaccin
differ
overal
boot
use
compart
avoid
contamin
unvaccin
calv
potenti
nasal
shed
vaccin
calv
clinic
examin
sampl
collect
perform
calv
one
three
day
arriv
unit
mean
age
day
sd
repeat
day
later
mean
age
day
sd
time
wean
descript
data
calv
enrol
studi
present
tabl
calv
gradual
wean
rear
day
calv
weight
measur
three
time
studi
period
time
arriv
unit
time
second
clinic
examin
right
transport
finish
unit
clinic
examin
includ
measur
bodi
temperatur
auscult
heart
lung
measur
respiratori
rate
heart
rate
inspect
nose
eye
discharg
record
ear
posit
palpat
inspect
umbilicu
joint
hoov
appear
cough
diarrhea
also
record
calf
score
base
gener
appear
clinic
examin
data
use
calcul
clinic
condit
score
brd
score
calf
clinic
condit
score
calcul
sum
score
clinic
examin
tabl
brd
diagnos
score
accord
third
three
score
system
love
colleagu
tabl
clinic
examin
done
veterinarian
research
group
clinic
examin
perform
blood
sampl
obtain
venipunctur
vena
jugulari
vacuum
system
ml
z
serum
clot
activ
vacuett
austria
releas
calf
pen
vaccin
group
singleus
plastic
nasal
cannula
zoeti
use
administ
ml
vaccin
nostril
calf
calv
examin
batch
one
group
vaccin
unvaccin
calv
examin
day
examin
alway
start
unvaccin
group
avoid
contamin
potenti
nasal
shed
vaccin
repeat
second
visit
throughout
studi
period
sign
diseas
treatment
mortal
calv
observ
record
daili
basi
farmer
sick
calv
treat
farmer
accord
instruct
farm
contract
veterinarian
medic
brd
start
two
follow
sign
recogn
increas
bodi
temperatur
sign
depress
loss
appetit
rapid
difficult
breath
primari
medic
respiratori
inflamm
combin
parenter
oxytetracyclin
parenter
nonsteroid
antiinflammatori
drug
nsaid
interdigit
phlegmon
umbil
inflamm
combin
parenter
benzylpenicillin
nsaid
use
primari
medic
date
treatment
togeth
observ
sign
bodi
temperatur
sign
depress
inappet
rapid
difficult
breath
cough
possibl
eye
nasal
discharg
diarrhea
interdigit
phlegmon
sign
diseas
medicin
use
precis
record
calf
serious
ill
untreat
herd
veterinarian
euthan
calf
due
welfar
reason
first
calf
tranquil
mgkg
xylazin
nerfasin
vet
mgml
le
vet
b
v
netherland
thereaft
mgkg
product
contain
pentobarbit
sodium
phenytoin
sodium
euthasol
vet
mgml
le
vet
bv
product
inject
jugular
vein
possibl
necropsi
done
calv
die
euthan
studi
period
blood
sampl
collect
transport
laboratori
store
styrofoam
box
cool
element
laboratori
blood
sampl
centrifug
rpm
min
separ
serum
isol
store
ml
tube
sarstedt
germani
analyz
bovin
igg
saa
concentr
igg
serum
sampl
analyz
use
commerci
elisa
kit
bovin
igg
elisa
quantit
set
cat
bethyl
laboratori
inc
montgomeri
tx
usa
dilut
detect
rang
mgml
mgml
respect
analysi
done
accord
manufactur
instruct
serum
saa
concentr
measur
commerci
avail
solid
phase
sandwich
elisa
kit
phase
tm
rang
multispeci
saa
elisa
kit
tridelta
develop
ltd
ireland
accord
manufactur
instruct
bovin
sampl
dilut
use
detect
rang
respect
accord
sampl
size
calcul
control
vaccin
calv
need
detect
differ
treatment
rate
studi
group
power
pvalu
consid
statist
signific
independ
ttest
use
compar
weight
age
clinic
condit
score
serum
igg
saa
concentr
calv
differ
vaccin
group
time
arriv
descript
data
present
tabl
linear
mix
regress
model
use
studi
associ
intranas
vaccin
daili
gain
calv
milkfeed
period
complet
studi
period
interact
detect
calf
age
arriv
vaccin
fig
two
separ
model
use
evalu
associ
vaccin
daili
gain
complet
studi
period
one
model
use
calv
day
older
time
arriv
anoth
model
calv
younger
day
addit
three
logist
mix
regress
model
use
studi
associ
intranas
vaccin
brd
diagnosi
second
clinic
examin
treat
brd
studi
period
death
calf
transport
finish
unit
transport
batch
use
random
factor
model
addit
vaccin
statu
vaccin
unvaccin
studi
sever
potenti
explanatori
covari
nomin
variabl
includ
sex
male
femal
breed
calv
ayrshir
holstein
dairybeef
cross
brd
diagnosi
first
clinic
examin
continu
variabl
includ
age
weight
calv
arriv
clinic
score
serum
igg
saa
concentr
time
first
clinic
examin
age
arriv
saa
concentr
logtransform
achiev
normal
distribut
better
suitabl
model
number
antimicrobi
treatment
per
calf
test
model
outcom
variabl
daili
gain
mortal
control
possibl
confound
effect
outcom
moreov
confound
effect
sex
breed
test
model
variabl
alreadi
includ
model
eg
case
univari
analys
chang
greater
variabl
coeffici
odd
ratio
defin
confound
biolog
meaning
twoway
interact
vaccin
fix
factor
test
statist
analys
perform
statamp
window
statacorp
lp
texa
usa
